Efficiency of collagen-containing implant in complex rehabilitation of patients with coxarthrosis

Authors:

Titukhov Renat Yurievich — ultrasound diagnostics doctor, SONAR LLC, 53A Blucher Street, 454087 Chelyabinsk, Chelyabinsk Region, Russian Federation; e-mail: renat999661@yandex.ru.

Gurova Natalya Evgenievna — doctor-surgeon, SONAR LLC, CNS LLC, 53A Blucher Street, 454087 Chelyabinsk, Chelyabinsk Region, Russian Federation; e-mail: natalyagur@mail.ru.

Sumnaya Dina Borisovna — Grand PhD in Medical sciences (Dr. Med. Sci.), Professor, Ural State University of Physical Culture, 1 Ordzhonikidze Street, 454091 Chelyabinsk, Chelyabinsk Region, Russian Federation; SONAR LLC, CNS LLC, 53A Blucher Street, 454087 Chelyabinsk, Chelyabinsk Region, Russian Federation; e-mail: sumniyd@mail.ru.

Sadova Valentina Alekseevna — PhD in Medical sciences (Cand. Med. Sci.), neurologist, SONAR LLC, CNS LLC, 53A Blucher Street, 454087 Chelyabinsk, Chelyabinsk Region, Russian Federation; e-mail: val.l@mail.ru.

Annotation:

Introduction. Primary coxarthrosis is one of the most common degenerative-dystrophic diseases of the hip joint. Coxarthrosis is characterized by a chronic progressive course, which leads to disability of patients, changes in their entire way of life, which makes the problem of treating this pathology not only medical, but also social.
The article presents the results of a clinical observational study on the experience of using a collagen-containing implant (hereinafter — CCI) in patients with osteoarthritis of the hip joint against the background of intraarticular injection of synovial fluid endoprostheses under ultrasound control with subsequent rehabilitation using instrumental mobilization (IM).

Aim. The aim of the study was to analyze the effectiveness of CCI in patients with osteoarthritis of the hip joint against the background of the introduction of synovial fluid endoprostheses under ultrasound control with subsequent rehabilitation.

Materials and methods. 44 people with osteoarthritis of the hip joint were under observation. CCI was administered under ultrasound guidance intraarticularly and periarticularly to 2 trigger points (trochanter and piriformis projection) once a week No. 5.The control group received basic therapy (chondroprotectors, NSAIDs and a single intra-articular injection of high molecular weight hyaluronic acid).

Results. The results of clinical observation demonstrated a decrease in pain syndrome, an increase in functional activity, positive changes in ligamentous tendon structures.

Discussion. The use of CCI satisfies the therapeutic need, allowing to obtain the best clinical results by affecting the periarticular tissues, which play a crucial role in the pathogenesis of osteoarthritis conditions. In the present study, the use of CCI allowed to accelerate the sanogenetic processes in patients with coxarthrosis without the development of additional side effects, which may be essential in the therapy, prevention of chronic and repeated exacerbations of pain syndrome in this category of patients.

Conclusion. The use of CCI made it possible to accelerate the sanogenetic processes in patients with coxarthrosis without the development of additional side effects.

List of cited literature:

1. Belyaeva EA, Fatenko AS, Kuznecova SV. Primenenie in»ekcionnogo kollagena pri osteoartrite u mul’timorbidnyh pacientov [The use of injectable collagen in osteoarthritis in multimorbid patients] Klinicheskaya medicina i farmakologiya [Clinical medicine and pharmacology]. 2022;8(3).40-4. (In Russian).

2. Randelli F, Menon A et al. Vliyanie MD-COLLAGEN na morfofunkcional’nye svojstva kul’tiviruemyh tenocitov cheloveka [Influence of MD-COLLAGEN on morphofunctional properties of cultured human tenocytes]. Pleksatron. Sbornik nauchnyh materialov [Plexatron. Collection of scientific materials]. 2021: 53-64. (In Russian).

3. Samarcev IN, Zhivolupov SA, Cherednichenko DV, Cosedov PYu. Otkrytoe issledovanie effektivnosti i perenosimosti Pleksatrona v lechenii pacientov s bol’yu v oblasti nizhnej chasti spiny (issledovanie PALACIO) [An open study of the effectiveness and tolerability of Plexatron in the treatment of patients with pain in the lower back (PALACIO study)]. 2021;(4):53-60. (In Russian).

4. Shostak NA, Pravdyuk NG. Miofascial’nyj sindrom (sindrom grushevidnoj myshcy)—podhody k diagnostike, lecheniyu [Myofascial syndrome (piriformis muscle syndrome) — approaches to diagnosis, treatment]. Rossijskij medicinskij zhurnal [Russian Medical Journal]. 2014;28:20-2. (In Russian).

5. Ricchetti ET, Aurora A, Iannotti JP, Derwin KA. Scaffold devices for rotator cuff repair. Journal of Shoulder and Elbow Surgery. 2012;12(2):251-65.

6. Siricyna YC, Sivakov AP. Miofascial’nyj sindrom: etiologiya, klinika, principy lecheniya [Myofascial syndrome: etiology, clinic, principles of treatment] Medicinskie Novosti [Medical news]. 2020;8(311):13-7. (In Russian).

7. Ruiu DE. Medical device iniettabili a base di collagene. Stato dell’arte e overview degli studi clinici. Advanced Therapies. 2012;(1):30-9.

8. Kannus P. Structure of the tendon connective tissue. Scandinavian Journal of Medicine & Science in Sports. 2000;10(6):312-20.

9. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiological Reviews. 2004;84(2):649-98.

10. Walker LC, Overstreet MA, Yeowell HN. Tissue-specific expression and regulation of the alternatively-spliced forms of lysyl hydroxylase 2 (LH2) in human kidney cells and skin fibroblasts. Matrix Biology. 2005; 23(8):515-23.

11. Drozdov VN, Shih EV, Serebrova sY, Abrosimov AG et al. Alflutop v sovremennoj simptom-modificiruyushchej terapii osteoartrita [Alflutop in modern symptommodifying therapy of osteoarthritis] Terapevticheskij arhiv [Therapeutic Archive]. 2019;91(5):134-40. (In Russian).